An unusual and severe case of paclitaxel‐induced hand‐foot syndrome

Abstract

Abstract Although paclitaxel is known to cause mild skin toxicity, it may induce severe HFS requiring drug withdrawal. Patients with high disease burden might receive prolonged paclitaxel chemotherapy. Hence, a grade 2 toxicity would better indicate withdrawal of paclitaxel instead of suspension and rechallenge, to prevent such severe HFS requiring long‐time recovery.

Keywords

• antineoplastic agents
• hand‐foot syndrome
• paclitaxel